Late gadolinium enhancement on cardiac magnetic resonance imaging: Is it associated with a higher incidence of nonsustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy?

Japanese Journal of Radiology

Volumn 28, Issue 5, 2010, Pages 355-361

  Kono, Atsushi K ^a,b   Ishii, Kazunari ^a   Kumagai, Hiroyuki ^b   Taniguchi, Yasuyo ^c   Kajiya, Teishi ^c   Sugimura, Kazuro ^b  

^a Hyogo Brain and Heart Center   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Division of Cardiovascular and Respiratory Medicine Department of Internal Medicine Kobe University Graduate School of Medicine ^*  (Japan)

Author keywords

Idiopathic dilated cardiomyopathy; Late gadolinium enhancement; MRI; Nonsustained ventricular tachycardia

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM PENTETATE; GADOLINIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; DEFIBRILLATOR; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; COMPARATIVE STUDY; COMPLICATION; DIAGNOSTIC USE; FIBROSIS; HEART; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; PROCEDURES; TACHYCARDIA, VENTRICULAR;

CARDIOMYOPATHY, DILATED; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FIBROSIS; GADOLINIUM; HEART; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR;

EID: 77955264438     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-010-0433-1     Document Type: Article

References (22)

1. Y. Matsumura J. Takata H. Kitaoka T. Kubo Y. Baba E. Hoshikawa, et al. 2006 Long-term prognosis of dilated cardiomyopathy revisited: an improvement in survival over the past 20 years Circ J 70 376 383 10.1253/circj.70.376 16565551
2. D. Bello D.S. Fieno R.J. Kim F.S. Pereles R. Passman G. Song, et al. 2005 Infarct morphology identifies patients with substrate for sustained ventricular tachycardia J Am Coll Cardiol 45 1104 1108 10.1016/j.jacc.2004.12.057 15808771 (Pubitemid 40432446)
3. S. Nazarian D.A. Bluemke A.C. Lardo M.M. Zviman S.P. Watkins T.L. Dickfeld, et al. 2005 Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy Circulation 112 2821 2825 10.1161/CIRCULATIONAHA.105.549659 16267255 (Pubitemid 41641676)
4. D. Bello D.J. Shah G.M. Farah S. Di Luzio M. Parker M.R. Johnson, et al. 2003 Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy Circulation 108 1945 1953 10.1161/01.CIR.0000095029.57483. 60 1:CAS:528:DC%2BD3sXotVeisr8%3D 14557364 (Pubitemid 37296539)
5. H. Tandri M. Saranathan E.R. Rodriguez C. Martinez C. Bomma K. Nasir, et al. 2005 Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging J Am Coll Cardiol 45 98 103 10.1016/j.jacc.2004.09.053 15629382 (Pubitemid 40052034)
6. O.P. Simonetti R.J. Kim D.S. Fieno H.B. Hillenbrand E. Wu J.M. Bundy, et al. 2001 An improved MR imaging technique for the visualization of myocardial infarction Radiology 218 215 223 1:STN:280:DC%2BD3MzitFCntg%3D%3D 11152805
7. E. Wu R.M. Judd J.D. Vargas F.J. Klocke R.O. Bonow R.J. Kim 2001 Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction Lancet 357 21 28 10.1016/S0140-6736(00)03567-4 1:STN:280:DC%2BD3M7gtV2huw%3D%3D 11197356 (Pubitemid 32056497)
8. D.C. Isbell C.M. Kramer 2006 The evolving role of cardiovascular magnetic resonance imaging in nonischemic cardiomyopathy Semin Ultrasound CT MR 27 20 31 10.1053/j.sult.2005.11.002 16562569 (Pubitemid 43287925)
9. J.A. McCrohon J.C. Moon S.K. Prasad W.J. McKenna C.H. Lorenz A.J. Coats, et al. 2003 Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance Circulation 108 54 59 10.1161/01.CIR.0000078641.19365.4C 1:STN:280:DC%2BD3szhslKgtw%3D%3D 12821550 (Pubitemid 36859020)
10. R.G. Assomull S.K. Prasad J. Lyne G. Smith E.D. Burman M. Khan, et al. 2006 Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 1977 1985 10.1016/j.jacc.2006.07.049 17112987 (Pubitemid 44738448)
11. P. Richardson W. McKenna M. Bristow B. Maisch B. Mautner J. O'Connell, et al. 1996 Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies Circulation 93 841 842 1:STN:280:DyaK287nvFSisg%3D%3D 8598070
12. C.M. Kramer J. Barkhausen S.D. Flamm R.J. Kim E. Nagel 2008 Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols J Cardiovasc Magn Reson 10 35 10.1186/1532-429X-10-35 18605997
13. R.J. Kim D.S. Fieno T.B. Parrish K. Harris E.L. Chen O. Simonetti, et al. 1999 Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1992 2002 1:STN:280:DC%2BD3c%2FivVensg%3D%3D 10556226
14. J.O. O'Neill P.M. McCarthy R.C. Brunken T. Buda K. Hoercher J.B. Young, et al. 2004 PET abnormalities in patients with nonischemic cardiomyopathy J Card Fail 10 244 249 10.1016/j.cardfail.2003.09.007 15190535 (Pubitemid 38869466)
15. P. Knaapen R. Boellaard M.J. Gotte P.A. Dijkmans L.M. van Campen C.C. de Cock, et al. 2004 Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy J Nucl Med 45 1299 1304 15299052
16. N. Maehashi Y. Yokota A. Takarada S. Usuki S. Maeda H. Yoshida, et al. 1991 The role of myocarditis and myocardial fibrosis in dilated cardiomyopathy: analysis of 28 necropsy cases Jpn Heart J 32 1 15 1:STN:280:DyaK3M3ksFKnug%3D%3D 2038116
17. J.C. Moon W.J. McKenna J.A. McCrohon P.M. Elliott G.C. Smith D.J. Pennell 2003 Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 1561 1567 10.1016/S0735-1097(03)00189-X 12742298 (Pubitemid 36543376)
18. M.D. Cerqueira N.J. Weissman V. Dilsizian A.K. Jacobs S. Kaul W.K. Laskey, et al. 2002 Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 539 542 10.1161/hc0402.102975 11815441 (Pubitemid 34262671)
19. H. Kasanuki Y. Aizawa T. Ohe 2001 Guideline for nonpharmacological therapy of cardiac arrhythmias Jpn Circ J 65 supplV 1127 1160
20. R.A. Winkle R.H. Mead M.A. Ruder V.A. Gaudiani N.A. Smith W.S. Buch, et al. 1989 Long-term outcome with the automatic implantable cardioverter- defibrillator J Am Coll Cardiol 13 1353 1361 10.1016/0735-1097(89)90310-0 1:STN:280:DyaL1M7pvValtA%3D%3D 2703616
21. E. Biagini F. Coccolo M. Ferlito E. Perugini G. Rocchi L. Bacchi-Reggiani, et al. 2005 Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients J Am Coll Cardiol 46 1543 1550 10.1016/j.jacc.2005.04.062 16226182 (Pubitemid 41446193)
22. H. Mahrholdt C. Goedecke A. Wagner G. Meinhardt A. Athanasiadis H. Vogelsberg, et al. 2004 Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology Circulation 109 1250 1258 10.1161/01.CIR.0000118493.13323.81 14993139 (Pubitemid 38379570)